Argenx
ARGX
#592
Rank
โ‚ฌ32.40 B
Marketcap
533,33ย โ‚ฌ
Share price
-5.42%
Change (1 day)
18.46%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Cash on Hand

Cash on Hand as of June 2024 : โ‚ฌ2.94 Billion

According to Argenx 's latest financial reports the company has โ‚ฌ2.94 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Argenx - Cash on Hand chart (from 2013 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2020-12-31โ‚ฌ1.99 B33.04%
2019-12-31โ‚ฌ1.50 B132.37%
2018-12-31โ‚ฌ0.64 B49.62%
2017-12-31โ‚ฌ0.43 B324.29%
2016-12-31โ‚ฌ0.10 B119.83%
2015-12-31โ‚ฌ46.27 M-32.01%
2014-12-31โ‚ฌ68.06 M112.28%
2013-12-31โ‚ฌ32.06 M47.12%
2012-12-31โ‚ฌ21.79 M-28.58%
2011-12-31โ‚ฌ30.51 M190.59%
2010-12-31โ‚ฌ10.5 M